Association of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade glioma - Archive ouverte HAL Access content directly
Journal Articles Neuro-Oncology Year : 2014

Association of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade glioma

(1, 2) , (1) , (2) , (2) , (2) , (3) , (4) , (5) , (6) , (1, 7) , (1, 8) , (9, 1)
1
2
3
4
5
6
7
8
9
Marc Sanson
Philippe Metellus
  • Function : Author
  • PersonId : 1002610

Dates and versions

hal-01707899 , version 1 (13-02-2018)

Identifiers

Cite

Emeline Tabouret, Françoise Boudouresque, Maryline Barrie, Mona Matta, Celine Boucard, et al.. Association of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade glioma. Neuro-Oncology, 2014, 16 (3), pp.392 - 399. ⟨10.1093/neuonc/not226⟩. ⟨hal-01707899⟩
67 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More